GERN vs WRB · rev $109.3M vs P/E 17, rev $3.72B
Geron Corporation (GERN) versus W. R. Berkley Corp (WRB) — a side-by-side from cached financials, not a winner call.
Geron Corporation (GERN) is a biotechnology company listed on US.
W. R. Berkley Corp (WRB) is a insurance - property & casualty company listed on US.
Latest reported GERN revenue for 2026-06-30 was $109.3M. Net income was -$20.3M. GERN currently screens at market cap $878.9M.
Latest reported WRB revenue for 2026-06-30 was $3.72B. Net income was $452.3M. Revenue was up 0.7% from 2026-03-31 to 2026-06-30. WRB currently screens at market cap $27.12B and trailing P/E 16.6.
GERN currently screens at market cap $878.9M. WRB currently screens at market cap $27.12B and trailing P/E 16.6.
Not investment advice. Open the GERN and WRB stock pages for the full models.
Not investment advice.